| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1046701869 |
| P356 | DOI | 10.1186/1742-2094-9-54 |
| P932 | PMC publication ID | 3359166 |
| P698 | PubMed publication ID | 22420334 |
| P5875 | ResearchGate publication ID | 221897280 |
| P50 | author | Laila Y Al-Ayadhi | Q56993849 |
| P2093 | author name string | Gehan Ahmed Mostafa | |
| P2860 | cites work | Intracellular and extracellular roles of S100 proteins | Q28184555 |
| How regulatory T cells work | Q29614262 | ||
| S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles | Q29620465 | ||
| Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions | Q30432850 | ||
| The economic impact of S-100B as a pre-head CT screening test on emergency department management of adult patients with mild traumatic brain injury | Q33657669 | ||
| Validation of serum markers for blood-brain barrier disruption in traumatic brain injury | Q33657728 | ||
| Peripheral markers of brain damage and blood-brain barrier dysfunction | Q33789473 | ||
| Serum S100B levels in patients with lupus erythematosus: preliminary observation | Q33941483 | ||
| Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease | Q34309107 | ||
| Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis | Q34309699 | ||
| Systemic markers of inflammation are independently associated with S100B concentration: results of an observational study in subjects with acute ischaemic stroke | Q34321555 | ||
| Circulating autoantibodies to neuronal and glial filament proteins in autism | Q34440250 | ||
| Evaluation of S-100b as a specific marker for neuronal damage due to minor head trauma | Q34647001 | ||
| Serum S-100B concentration provides additional information fot the indication of computed tomography in patients after minor head injury: a prospective multicenter study | Q34652236 | ||
| Autoantibodies in neuropsychiatric lupus. | Q34692563 | ||
| Autoimmunity in autism. | Q34980345 | ||
| Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity. | Q35016370 | ||
| A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children | Q35123969 | ||
| Low plasma progranulin levels in children with autism | Q35240854 | ||
| Raised serum S100B protein levels in neuropsychiatric lupus. | Q35637257 | ||
| The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism | Q35682478 | ||
| S100B in schizophrenic psychosis | Q35684744 | ||
| Anti-ribosomal P protein antibodies | Q36086145 | ||
| Immunological findings in autism | Q36411543 | ||
| Clinical and biological aspects of anti-P-ribosomal protein autoantibodies | Q36731825 | ||
| Lipid peroxidation-derived aldehyde-protein adducts contribute to trichloroethene-mediated autoimmunity via activation of CD4+ T cells | Q36737666 | ||
| Biological and methodological features of the measurement of S100B, a putative marker of brain injury | Q37153830 | ||
| The effects of immunosuppression on regulatory CD4(+)CD25(+) T cells: impact on immunosuppression selection in transplantation | Q37176386 | ||
| The significance of protein S-100B testing in cardiac arrest patients | Q37860511 | ||
| Comparative immunogenetics of autism and schizophrenia | Q37886065 | ||
| Frequency of CD4+CD25high regulatory T cells in the peripheral blood of Egyptian children with autism | Q39273868 | ||
| The link of C4B null allele to autism and to a family history of autoimmunity in Egyptian autistic children | Q39273880 | ||
| Oxidative stress in Egyptian children with autism: relation to autoimmunity | Q39273888 | ||
| Serum anti-nuclear antibodies as a marker of autoimmunity in Egyptian autistic children | Q39273901 | ||
| Serum anti-myelin-associated glycoprotein antibodies in Egyptian autistic children | Q39273913 | ||
| Increased Prevalence of Familial Autoimmunity in Probands With Pervasive Developmental Disorders | Q40547096 | ||
| The extracellular calcium-sensing receptor is required for calcium-induced differentiation in human keratinocytes | Q43704278 | ||
| Effect of the atypical neuroleptic risperidone on morphology and S100B secretion in C6 astroglial lineage cells. | Q43862114 | ||
| Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction | Q45167064 | ||
| Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients | Q45251159 | ||
| Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism | Q45753637 | ||
| The role of measurement of serum autoantibodies in prediction of pediatric neuropsychiatric systemic lupus erythematosus | Q46829495 | ||
| Prevalence of serum antibodies to caudate nucleus in autistic children | Q48091807 | ||
| Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome | Q48109399 | ||
| Total tau and S100b proteins in different types of multiple sclerosis and during immunosuppressive treatment with mitoxantrone | Q48144177 | ||
| Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system | Q48258725 | ||
| Antibodies to Myelin Basic Protein in Children with Autistic Behavior | Q48329357 | ||
| S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke | Q48613065 | ||
| Increased frequency of the null allele at the complement C4b locus in autism | Q50306315 | ||
| Confirmation of the association of the C4B null allelle in autism | Q50306804 | ||
| Increased serum osteopontin levels in autistic children: relation to the disease severity. | Q50311242 | ||
| Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism | Q50313816 | ||
| Infections, Toxic Chemicals and Dietary Peptides Binding to Lymphocyte Receptors and Tissue Enzymes are Major Instigators of Autoimmunity in Autism | Q50343146 | ||
| The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous system. | Q52105657 | ||
| [S100B: pathogenetic and pathophysiologic significance in neurology] | Q53224381 | ||
| Myelin basic protein and S-100 antigen in cerebrospinal fluid of patients with multiple sclerosis in the acute phase | Q69383606 | ||
| Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury | Q73205752 | ||
| A specific and sensitive ELISA for measuring S-100b in cerebrospinal fluid | Q73543859 | ||
| [S-100 beta protein in serum, a tumor marker in malignant melanoma-- current state of knowledge and clinical experience] | Q77831457 | ||
| Expression of S100B protein levels in serum and cerebrospinal fluid with different forms of neuropsychiatric systemic lupus erythematosus | Q81484705 | ||
| Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies | Q81510790 | ||
| [The clinical importance of anti-ribosomal-P antibodies] | Q84941665 | ||
| P921 | main subject | autism | Q38404 |
| autistic child | Q110955678 | ||
| P304 | page(s) | 54 | |
| P577 | publication date | 2012-03-16 | |
| P1433 | published in | Journal of Neuroinflammation | Q15716679 |
| P1476 | title | A lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children | |
| P478 | volume | 9 |
| Q62111589 | A systematic review of gut-immune-brain mechanisms in Autism Spectrum Disorder |
| Q42756128 | Activity-Regulated Cytoskeleton-Associated Protein Dysfunction May Contribute to Memory Disorder and Earlier Detection of Autism Spectrum Disorders |
| Q36039435 | Association between Asthma and Autism Spectrum Disorder: A Meta-Analysis |
| Q21129103 | Biomarkers in autism |
| Q34373512 | Camel Milk as a Potential Therapy as an Antioxidant in Autism Spectrum Disorder (ASD). |
| Q89780531 | Chronic maternal interleukin-17 and autism-related cortical gene expression, neurobiology, and behavior |
| Q90706593 | Do Alarmins Have a Potential Role in Autism Spectrum Disorders Pathogenesis and Progression? |
| Q34394723 | Effect of camel milk on thymus and activation-regulated chemokine in autistic children: double-blind study |
| Q47824514 | Elevated plasma concentrations of S100 calcium-binding protein B and tumor necrosis factor alpha in children with autism spectrum disorders. |
| Q36136811 | Elevated serum levels of interleukin-17A in children with autism. |
| Q36992632 | Elevated serum levels of macrophage-derived chemokine and thymus and activation-regulated chemokine in autistic children |
| Q22241227 | Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism |
| Q35994564 | Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma |
| Q37542184 | Peripheral Inflammatory Markers Contributing to Comorbidities in Autism. |
| Q89821997 | Probiotics and oxytocin nasal spray as neuro-social-behavioral interventions for patients with autism spectrum disorders: a pilot randomized controlled trial protocol |
| Q37661363 | Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala |
| Q36333214 | Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: relation to autoimmunity |
| Q36749836 | S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression |
| Q37688416 | Serum antinucleosome-specific antibody as a marker of autoimmunity in children with autism. |
| Q48702045 | The positive association between elevated blood lead levels and brain-specific autoantibodies in autistic children from low lead-polluted areas |
Search more.